<html><body><pre>[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4586 Introduced in House (IH)]

&lt;DOC&gt;






114th CONGRESS
  2d Session
                                H. R. 4586

 To amend the Public Health Service Act to authorize grants to States 
for developing standing orders and educating health care professionals 
regarding the dispensing of opioid overdose reversal medication without 
         person-specific prescriptions, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                           February 23, 2016

 Mr. Dold (for himself and Ms. Clark of Massachusetts) introduced the 
   following bill; which was referred to the Committee on Energy and 
                                Commerce

_______________________________________________________________________

                                 A BILL


 
 To amend the Public Health Service Act to authorize grants to States 
for developing standing orders and educating health care professionals 
regarding the dispensing of opioid overdose reversal medication without 
         person-specific prescriptions, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as ``Lali's Law''.

SEC. 2. OPIOID OVERDOSE REVERSAL MEDICATION ACCESS AND EDUCATION GRANT 
              PROGRAMS.

    Part B of title III of the Public Health Service Act is amended by 
inserting after section 317T of such Act (42 U.S.C. 247b-22) the 
following:

``SEC. 317U. OPIOID OVERDOSE REVERSAL MEDICATION ACCESS AND EDUCATION 
              GRANT PROGRAMS.

    ``(a) Grants to States.--The Secretary, acting through the Director 
of the Centers for Disease Control and Prevention, may make grants to 
States for--
            ``(1) developing standing orders for pharmacies regarding 
        opioid overdose reversal medication;
            ``(2) encouraging pharmacies to dispense opioid overdose 
        reversal medication pursuant to a standing order;
            ``(3) implementing guidelines and best practices for 
        persons authorized to prescribe medication regarding--
                    ``(A) prescribing opioids for the treatment of 
                chronic pain;
                    ``(B) co-prescribing opioid overdose reversal 
                medication with opioids; and
                    ``(C) discussing the purpose and administration of 
                opioid overdose reversal medication with patients;
            ``(4) developing or adapting training materials and methods 
        for persons authorized to prescribe or dispense medication to 
        use in educating the public regarding--
                    ``(A) when and how to administer opioid overdose 
                reversal medication; and
                    ``(B) steps to be taken after administering opioid 
                overdose reversal medication; and
            ``(5) educating the public regarding--
                    ``(A) the public health benefits of opioid overdose 
                reversal medication; and
                    ``(B) the availability of opioid overdose reversal 
                medication without a person-specific prescription.
    ``(b) Certain Requirement.--A grant may be made under this section 
only if the State involved has authorized standing orders regarding 
opioid overdose reversal medication.
    ``(c) Preference in Making Grants.--In making grants under this 
section, the Secretary shall give preference to States that--
            ``(1) have not issued standing orders regarding opioid 
        overdose reversal medication;
            ``(2) authorize standing orders that permit community-based 
        organizations, substance abuse programs, or other nonprofit 
        entities to acquire, dispense, or administer opioid overdose 
        reversal medication;
            ``(3) authorize standing orders that permit police, fire, 
        or emergency medical services agencies to acquire and 
        administer opioid overdose reversal medication;
            ``(4) have a higher per capita rate of opioid overdoses 
        than other applicant States; or
            ``(5) meet any other criteria deemed appropriate by the 
        Secretary.
    ``(d) Grant Terms.--
            ``(1) Number.--A State may not receive more than 1 grant 
        under this section.
            ``(2) Period.--A grant under this section shall be for a 
        period of 3 years.
            ``(3) Amount.--A grant under this section may not exceed 
        $500,000.
            ``(4) Limitation.--A State may use not more than 20 percent 
        of a grant under this section for educating the public pursuant 
        to subsection (a)(5).
    ``(e) Applications.--To be eligible to receive a grant under this 
section, a State shall submit an application to the Secretary in such 
form and manner and containing such information as the Secretary may 
require, including detailed proposed expenditures of grant funds.
    ``(f) Reporting.--Not later than 3 months after the Secretary 
disburses the first grant payment to any State under this section and 
every 6 months thereafter for 3 years, such State shall submit a report 
to the Secretary that includes the following:
            ``(1) The name and ZIP Code of each pharmacy in the State 
        that dispenses opioid overdose reversal medication under a 
        standing order.
            ``(2) The total number of opioid overdose reversal 
        medication doses dispensed by each such pharmacy, specifying 
        how many were dispensed with or without a person-specific 
        prescription.
            ``(3) The number of pharmacists in the State who have 
        participated in training pursuant to subsection (a)(4).
    ``(g) Definitions.--In this section:
            ``(1) Opioid overdose reversal medication.--The term 
        `opioid overdose reversal medication' means any drug, including 
        naloxone, that--
                    ``(A) blocks opioids from attaching to, but does 
                not itself activate, opioid receptors; or
                    ``(B) inhibits the effects of opioids on opioid 
                receptors.
            ``(2) Standing order.--The term `standing order' means a 
        document prepared by a person authorized to prescribe 
        medication that permits another person to acquire, dispense, or 
        administer medication without a person-specific prescription.
    ``(h) Authorization of Appropriations.--
            ``(1) In general.--To carry out this section, there is 
        authorized to be appropriated $10,815,000 for the period of 
        fiscal years 2016 through 2019.
            ``(2) Administrative costs.--Not more than 3 percent of the 
        amounts made available to carry out this section may be used by 
        the Secretary for administrative expenses of carrying out this 
        section.''.
                                 &lt;all&gt;
</pre></body></html>
